第一单位：
Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.;Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
作者：
Nicolás,Herranz [1]
;
Suchira,Gallage [2]
;
Massimiliano,Mellone [3]
;
Torsten,Wuestefeld [4]
;
Sabrina,Klotz [5]
;
Christopher J,Hanley [3]
;
Selina,Raguz [1]
;
Juan Carlos,Acosta [1]
;
Andrew J,Innes [1]
;
Ana,Banito [1]
;
Athena,Georgilis [1]
;
Alex,Montoya [6]
;
Katharina,Wolter [5]
;
Gopuraja,Dharmalingam [7]
;
Peter,Faull [6]
;
Thomas,Carroll [7]
;
Juan Pedro,Martínez-Barbera [8]
;
Pedro,Cutillas [9]
;
Florian,Reisinger [10]
;
Mathias,Heikenwalder [11]
;
Richard A,Miller [12]
;
Dominic,Withers [13]
;
Lars,Zender [5]
;
Gareth J,Thomas [3]
;
Jesús,Gil [14]
作者单位：
Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.;Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
[1]
Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.;Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.;Metabolic Signalling Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
[2]
Cancer Sciences Unit, Cancer Research UK Centre, Somers Building, University of Southampton, Southampton, UK.
[3]
Division of Molecular Oncology of Solid Tumors, Department of Internal Medicine I, Eberhard Karls University Tübingen, Tübingen, Germany.;Stem Cell & Regenerative Biology, Genome Institute of Singapore, Singapore, Singapore.
[4]
Division of Molecular Oncology of Solid Tumors, Department of Internal Medicine I, Eberhard Karls University Tübingen, Tübingen, Germany.
[5]
Proteomics Facility, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
[6]
Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
[7]
Developmental Biology and Cancer Programme, Birth Defects Research Centre, UCL Institute of Child Health, London, UK.
[8]
Proteomics Facility, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.;Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK.
[9]
Institute for Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
[10]
Institute for Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.;Division of Chronic Inflammation and Cancer, German Cancer Research (DKFZ), Heidelberg, Germany.
[11]
Department of Pathology and Geriatrics Center, University of Michigan, Ann Arbor, Michigan, USA.
[12]
Metabolic Signalling Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.
[13]
Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK. jesus.gil@csc.mrc.ac.uk.;Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK. jesus.gil@csc.mrc.ac.uk.
[14]
DOI
10.1038/s41556-024-01443-6
PMID
38778130
发布时间
2025-05-30
换一批
